Literature DB >> 3619422

Penetration of ciprofloxacin into cerebrospinal fluid of patients with bacterial meningitis.

M Wolff, L Boutron, E Singlas, B Clair, J M Decazes, B Regnier.   

Abstract

We evaluated the diffusion of ciprofloxacin into the cerebrospinal fluid (CSF) in 23 patients with bacterial meningitis or ventriculitis undergoing treatment with other antibiotics. Three successive ciprofloxacin doses of 200 mg were administered intravenously at 12-h intervals, first between days 2 and 4 and again between days 10 and 20 after the admission. Concentrations of ciprofloxacin in plasma and CSF obtained at 60, 120, 240, and 480 min after the third infusion were determined by high-performance liquid chromatography. In addition, serial samples were obtained from ventricular fluid in four patients. The concentrations of ciprofloxacin in CSF ranged from 0.35 to 0.56 micrograms/ml. These concentrations were equal to or higher than the MICs for most of the enterobacteria.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3619422      PMCID: PMC284207          DOI: 10.1128/AAC.31.6.899

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  4 in total

1.  Successful treatment of Pseudomonas ventriculitis with ciprofloxacin.

Authors:  D Isaacs; M P Slack; A R Wilkinson; A W Westwood
Journal:  J Antimicrob Chemother       Date:  1986-04       Impact factor: 5.790

2.  Ciprofloxacin for Pseudomonas aeruginosa meningitis.

Authors:  M R Millar; M A Bransby-Zachary; D S Tompkins; P M Hawkey; R Myles Gibson
Journal:  Lancet       Date:  1986-06-07       Impact factor: 79.321

3.  Ciprofloxacin in experimental Pseudomonas aeruginosa meningitis in rabbits.

Authors:  C J Hackbarth; H F Chambers; F Stella; A M Shibl; M A Sande
Journal:  J Antimicrob Chemother       Date:  1986-11       Impact factor: 5.790

4.  Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria.

Authors:  N X Chin; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

  4 in total
  20 in total

1.  Penetration of rufloxacin into the cerebrospinal fluid in patients with inflamed and uninflamed meninges.

Authors:  M V Moretti; S Pauluzzi; M Cesana
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

Review 2.  Comparative pharmacokinetics and pharmacodynamics of the newer fluoroquinolone antibacterials.

Authors:  A Aminimanizani; P Beringer; R Jelliffe
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

3.  In vitro bactericidal activity of amoxicillin, gentamicin, rifampicin, ciprofloxacin and trimethoprim-sulfamethoxazole alone or in combination against Listeria monocytogenes.

Authors:  A Boisivon; C Guiomar; C Carbon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-03       Impact factor: 3.267

4.  Overton's rule helps to estimate the penetration of anti-infectives into patients' cerebrospinal fluid.

Authors:  Marija Djukic; Martin Munz; Fritz Sörgel; Ulrike Holzgrabe; Helmut Eiffert; Roland Nau
Journal:  Antimicrob Agents Chemother       Date:  2011-11-21       Impact factor: 5.191

5.  Pharmacokinetic quantification of the exchange of drugs between blood and cerebrospinal fluid in man.

Authors:  R Nau; G Zysk; A Thiel; H W Prange
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 6.  Pefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J P Gonzalez; J M Henwood
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

Review 7.  Pharmacokinetic and Pharmacodynamic Principles of Anti-infective Dosing.

Authors:  Nikolas J Onufrak; Alan Forrest; Daniel Gonzalez
Journal:  Clin Ther       Date:  2016-07-20       Impact factor: 3.393

Review 8.  Clinical pharmacokinetics of ciprofloxacin.

Authors:  K Vance-Bryan; D R Guay; J C Rotschafer
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

Review 9.  Ventriculitis caused by Klebsiella pneumoniae successfully treated with pefloxacin in a neonate.

Authors:  N Linder; R Dagan; J Kuint; N Keler; G Keren; B Reichman
Journal:  Infection       Date:  1994 May-Jun       Impact factor: 3.553

Review 10.  Clinical pharmacokinetics of the newer antibacterial 4-quinolones.

Authors:  M Neuman
Journal:  Clin Pharmacokinet       Date:  1988-02       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.